This inventor holds 2 USPTO granted patents. Top assignees: Keio University, King Jim Co., Ltd.. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Masatoshi Hirayama: Innovator in Stem Cell Research and Device Technology
Introduction
Masatoshi Hirayama is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the fields of stem cell research and device technology. With a total of two patents to his name, Hirayama's work has the potential to impact medical science and technology.
Latest Patents
Hirayama's latest patents include a method of deriving lacrimal gland epithelial cells from embryonic stem (ES) cells and other stem cells. This innovative method provides a way to produce lacrimal gland epithelial cells from pluripotent stem cells. The process involves increasing the expression of the Pax6 gene and either the Foxc1 or Foxp1 genes in the pluripotent stem cells. Additionally, he has developed a tape printing device that showcases his versatility as an inventor.
Career Highlights
Throughout his career, Masatoshi Hirayama has worked with notable organizations such as King Jim Co., Ltd. and Keio University. His experience in these institutions has allowed him to refine his skills and contribute to groundbreaking research and development.
Collaborations
Hirayama has collaborated with esteemed colleagues, including Hiroaki Tanaka and Satomi Ohdan. These partnerships have further enriched his work and expanded the scope of his inventions.
Conclusion
Masatoshi Hirayama is a distinguished inventor whose work in stem cell research and device technology continues to pave the way for future innovations. His contributions are invaluable to both the scientific community and the advancement of medical technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

